Quick summary

Isomaltulose is a disaccharide carbohydrate used as a slow-digesting sugar source. It is studied for its potential energy support benefits and impact on metabolic responses, but comprehensive human clinical evidence for specific health benefits or safety profiles is currently pending.

What is it?

Isomaltulose, also known chemically as Palatinose disaccharide, is a carbohydrate classified as a reducing sugar. It is composed of glucose and fructose linked by an alpha-1,6 glycosidic bond. Unlike common table sugar (sucrose), isomaltulose is digested more slowly, resulting in a lower glycemic response. It is used as an alternative sugar primarily for this slower digestion profile.

How it may work in the body

Isomaltulose provides a slower release of glucose compared to regular sugar, which may help modulate blood sugar levels and provide sustained energy. The proposed mechanisms of action include:

  • Slow enzymatic hydrolysis in the small intestine leading to gradual glucose absorption
  • Lower glycemic index resulting in reduced postprandial blood glucose spikes
  • Potential impact on insulin secretion kinetics due to slower carbohydrate digestion

However, mechanistic understanding is mainly derived from in vitro and metabolic studies. Human clinical evidence linking these mechanisms to specific health outcomes remains limited or pending.

Common supplement forms

Isomaltulose is primarily available as a carbohydrate ingredient incorporated into various food products and beverages designed as sugar alternatives. There are no widely available isolated supplement forms such as capsules or powders commonly marketed solely as isomaltulose supplements.

Typical dosage and how it is used

There is no established official recommended daily intake for isomaltulose. Human clinical studies with isomaltulose have used varying dosages, but there are no consensus intake recommendations at this time.

Because isomaltulose is used principally as a sugar substitute, typical daily intake would depend on the amount of food or beverages consumed containing isomaltulose rather than on a supplement dosage schedule.

Note: No official recommended daily intake is established for isomaltulose.

Natural sources

Isomaltulose is not commonly found naturally in significant amounts in foods. It is primarily produced industrially by enzymatic rearrangement of sucrose. Thus, natural dietary sources are negligible or absent.

Absorption and bioavailability

Isomaltulose is digested more slowly than sucrose, resulting in a slower and more moderate rise in blood glucose and insulin levels. It is well absorbed in the small intestine but with delayed absorption kinetics compared to common sugars. This slower digestion contributes to its lower glycemic index.

Currently, there is no evidence of significant differences in absorption among different supplement forms, nor clear data on enhancers or inhibitors of its bioavailability.

Potential benefits: what does the evidence say?

Energy metabolism and glycemic response

Preliminary studies suggest isomaltulose may support more stable blood glucose and insulin responses compared to sucrose. This could potentially provide steadier energy release and reduce post-meal glucose spikes. However, robust human clinical evidence confirming consistent health benefits or metabolic improvements is pending.

Limitations of the evidence include a lack of multiple high-quality randomized clinical trials and systematic reviews. Most current data comes from preliminary studies or mechanistic investigations.

Side effects and safety

There is limited information available on the safety profile of isomaltulose supplementation. No common side effects or contraindications have been well documented in the literature so far, but evidence remains insufficient to fully assess safety or adverse effects.

Drug and supplement interactions

No reliable data exist regarding interactions between isomaltulose and drugs or other supplements. Due to the limited evidence, cautious use is advised, especially for those using medications affecting blood sugar or metabolism.

Who should be careful?

Individuals with metabolic conditions such as diabetes or impaired glucose tolerance should exercise caution with isomaltulose use and consult healthcare professionals before consumption. Similarly, people on medications affecting blood sugar or insulin should seek medical advice prior to using products containing isomaltulose.

Pregnancy, breastfeeding and special populations

Currently, there is insufficient evidence to establish safety or recommend isomaltulose supplementation during pregnancy or breastfeeding. People who are pregnant, breastfeeding, have medical conditions, use medication, or are planning surgery should consult a healthcare professional before consuming isomaltulose-containing products.

Quality, standardization and what to look for

Since isomaltulose is primarily used as a food ingredient, quality considerations revolve around product purity, manufacturing standards, and absence of contaminants. Consumers choosing products containing isomaltulose should select those made by reputable manufacturers adhering to good manufacturing practices (GMP).

Frequently asked questions

  • Is isomaltulose natural?
    It is produced industrially through enzymatic conversion of sucrose and is not found in significant amounts naturally in foods.
  • Does isomaltulose taste like sugar?
    Yes, it has a similar sweet taste to sugar but with slower digestion and less impact on blood sugar.
  • Is isomaltulose safe for diabetics?
    Early evidence suggests a lower glycemic response, but people with diabetes should consult healthcare professionals before use.
  • Are there official guidelines on how much to consume?
    No official recommended daily intake or dosage is established for isomaltulose.
  • Does isomaltulose have EU-authorized health claims?
    Currently, there are no EU-authorized health claims for isomaltulose.

Evidence limitations

  • Insufficient human clinical data available to confirm efficacy or safety.
  • No official recommended dosage or intake established.
  • Limited information on long-term use and safety.
  • Lack of EU-authorized health claims for isomaltulose.

References

Disclaimer

This page provides information based on currently available scientific evidence and is intended for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Individuals who are pregnant, breastfeeding, have a medical condition, are taking medication, or are planning surgery should consult their healthcare professional before using isomaltulose or related products.

Last reviewed

June 2024